To hear about similar clinical trials, please enter your email below

Trial Title: Discovering Novel Cancer Treatment Options Using a Comprehensive NGS-based Liquid Molecular Testing Panel in the Community Setting ("DINOSAur II")

NCT ID: NCT05703243

Condition: Stage III Solid Tumors
Stage IV Solid Tumors

Conditions: Official terms:
Neoplasms

Study type: Observational [Patient Registry]

Overall status: Recruiting

Study design:

Time perspective: Prospective

Intervention:

Intervention type: Diagnostic Test
Intervention name: Comprehensive liquid molecular panel test
Description: Lab test
Arm group label: Active

Intervention type: Other
Intervention name: EORTC QLQ-30
Description: Quality of life questionnaire
Arm group label: Active

Summary: To prospectively identify cancer patients whose tumors express specific molecular markers targeted by therapeutic agents from a comprehensive l i q u i d molecular test, for the purpose of selecting the most clinically appropriate treatment in a pragmatic two arm trial.

Criteria for eligibility:

Study pop:
Newly diagnosed cancer patients at the pathology level

Sampling method: Probability Sample
Criteria:
Inclusion Criteria: - Patients who have given informed consent in accordance with the methods and procedures of this study - Diagnosis of cancer (stage 3 and stage 4; solid tumors only) requiring medical care - Patients who have not received treatment related to his/her cancer - Patients who are willing to sign a release of medical records to the research team - Male and female patients ≥18 years of age - Patients under oncology care - Sufficient clinical status for collection of blood sample within usual care Exclusion Criteria: - Patients considered minors in the jurisdiction where the protocol is conducted - Patients who are prisoners and pregnant women - Patients who cannot provide consent and did not sign a power of attorney

Gender: All

Minimum age: 18 Years

Maximum age: N/A

Healthy volunteers: No

Locations:

Facility:
Name: Adventist Health Glendale

Address:
City: Glendale
Zip: 91206
Country: United States

Status: Recruiting

Contact:
Last name: Mihran Shirinian, M.D.

Phone: 818-543-7574
Email: mshirin@aol.com

Investigator:
Last name: Mihran Shirinian, M.D.
Email: Principal Investigator

Start date: February 1, 2023

Completion date: January 1, 2025

Lead sponsor:
Agency: Glendale Adventist Medical Center d/b/a Adventist Health Glendale
Agency class: Other

Collaborator:
Agency: Guardant Health, Inc.
Agency class: Industry

Source: Glendale Adventist Medical Center d/b/a Adventist Health Glendale

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT05703243

Login to your account

Did you forget your password?